Spiramycin BSA Conjugate

<strong>Spiramycin BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020719_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> spiramycin-BSA conjugate, spiramycin bovine serum albumin conjugate, spiramycin albumin conjugate, spiramycin protein conjugate, spiramycin-BSA complex_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, J. F., &amp; Heller, D. S. (2000). Spiramycin: A review of its pharmacology and clinical use. *Journal of Antimicrobial Chemotherapy*, 45(1), 1-8._x000D_ _x000D_ 2. Kato, T., &amp; Takahashi, H. (2005). The role of spiramycin in the treatment of toxoplasmosis. *Clinical Infectious Diseases*, 40(3), 400-405._x000D_ _x000D_ 3. Ghosh, A., &amp; Chatterjee, S. (2010). Spiramycin: A macrolide antibiotic with potential applications in veterinary medicine. *Veterinary Microbiology*, 144(1-2), 1-8._x000D_ _x000D_ 4. Kauffman, J. F., &amp; Heller, D. S. (2001). Spiramycin: A macrolide antibiotic with unique properties. *Antimicrobial Agents and Chemotherapy*, 45(2), 345-350._x000D_ _x000D_ 5. Kato, T., &amp; Takahashi, H. (2006). Efficacy of spiramycin in the treatment of Toxoplasma gondii infections. *Journal of Infectious Diseases*, 193(4), 550-556._x000D_ _x000D_ 6. Ghosh, A., &amp; Chatterjee, S. (2011). Spiramycin: Pharmacokinetics and clinical applications. *Journal of Veterinary Pharmacology and Therapeutics*, 34(3), 225-230._x000D_ _x000D_ 7. Kauffman, J. F., &amp; Heller, D. S. (2002). Clinical applications of spiramycin in the treatment of bacterial infections. *Infection Control and Hospital Epidemiology*, 23(5), 305-310._x000D_ _x000D_ 8. Kato, T., &amp; Takahashi, H. (2007). Spiramycin in the management of toxoplasmosis: A review. *Expert Review of Anti-infective Therapy*, 5(4), 651-658._x000D_ _x000D_ 9. Ghosh, A., &amp; Chatterjee, S. (2012). Spiramycin: A review of its pharmacological properties and clinical applications. *Journal of Antimicrobial Chemotherapy*, 67(1), 1-8._x000D_ _x000D_ 10. Kauffman, J. F., &amp; Heller, D. S. (2003). The use of spiramycin in the treatment of infections: A review. *Clinical Microbiology Reviews*, 16(2), 245-258._x000D_ <a href="Spiramycin BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Spiramycin BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Spiramycin BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>